News

More than 40% of people living with HIV rely on Medicaid for that medicine, according to AIDS United, a national advocacy ...
South Africa’s government has estimated that universities and science councils could lose about $107 million in U.S. research ...
FRIDAY, July 11, 2025 (HealthDay News) — Global deaths from AIDS have dropped to their lowest levels in more than 30 years, ...
In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...
A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global ...
The withdrawal of U.S. funding under the Trump administration has halted key HIV vaccine trials in South Africa, part of a ...
Senate Republicans remain wary of eliminating the popular and successful global HIV/AIDS program PEPFAR, as they face down a ...
Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
Severe cuts to international aid are disrupting lifesaving HIV services in vulnerable countries, with UNAIDS warning of millions of preventable infections and deaths if support isn’t restored.
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care   The Big Story Global HIV program a ...